Structure-activity relationship study of E6 as a novel necroptosis inducer

Area of Science:

• Oncology
• Molecular Biology
• Medicinal Chemistry

Background:

• Drug-resistant cancers pose a significant therapeutic challenge.
• Necroptosis (programmed necrosis) is an emerging target for cancer therapy.
• E6 is a recently identified potent and selective inducer of necroptosis.

Purpose of the Study:

• To explore structure-activity relationships of E6.
• To identify novel necroptosis inducers with potential anticancer activity.
• To investigate functionalized biphenyl derivatives as potential necroptosis inducers.

Main Methods:

• Chemical synthesis and structural modification of the E6 compound.
• Evaluation of synthesized compounds for necroptosis induction activity.
• Identification and characterization of lead compounds.

Main Results:

• Demonstrated for the first time that functionalized biphenyl derivatives exhibit necroptosis inducer activity.
• Identified two novel compounds, designated 5h and 5j.
• Compounds 5h and 5j showed significant potential as necroptosis inducers.

Conclusions:

• Functionalized biphenyl derivatives represent a new class of necroptosis inducers.
• Compounds 5h and 5j are promising candidates for further preclinical development.
• These findings open new avenues for developing treatments for drug-resistant cancers.